GEN Exclusives

More »

GEN News Highlights

More »
Jan 11, 2007

Bio-Rad Obtains License to Axis-Shield’s RA Test

  • Bio-Rad gained access to Axis-Shield's test for the early detection of rheumatoid arthritis. The assay will run on Bio-Rad's BioPlex® 2200 system and will test for anticyclic citrullinated peptide antibodies.

    "The ability to incorporate an anti-CCP test as part of a rheumatoid arthritis panel will add significantly to our growing menu of autoimmune tests on the BioPlex 2200 system," points out John Goetz, Bio-Rad vp and group manager of clinical diagnostics. "As the first and only fully automated, random access multiplex testing platform, the BioPlex 2200 system is ideally suited as a platform for multimarker autoimmune testing that includes rheumatoid arthritis."



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?